FBRX
Closed
Forte Biosciences Inc
12.44
-0.49 (-3.79%)
Last Update: 01 Jul 2025 23:00:00
Yesterday: 12.93
Day's Range: 11.7 - 13.48
Send
sign up or login to leave a comment!
When Written:
1.01
Forte Biosciences Inc. is a clinical-stage biopharmaceutical company that develops and commercializes novel therapeutics for the treatment of inflammatory skin diseases and other related disorders. The company is headquartered in California, USA, and was founded in 2016. Forte Biosciences' lead product candidate, FB-401, is a live biotherapeutic that targets the underlying cause of atopic dermatitis, a chronic inflammatory skin disease. The company is also developing other products, including FB-201, a topical treatment for psoriasis, and FB-301, a treatment for acne. Forte Biosciences is focused on leveraging its proprietary microbiome platform to develop innovative therapies that can address unmet medical needs in dermatology and other therapeutic areas. The company is listed on the Nasdaq stock exchange under the ticker symbol "FBRX."
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
sign up or login to leave a comment!!








